Home › Sjogren's Syndrome › North Carolina
Pag-aaral pangklinika para sa Sjogren's Syndrome sa North Carolina
6 pag-aaral para sa Sjogren's Syndrome ang naghahanap ng mga kalahok sa mga site sa North Carolina.
Mga Lungsod sa North Carolina
Opisyal na teksto ng pag-aaral (English)
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- On Site Clinical Solutions Llc, Charlotte
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07621809Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Arthritis and Osteoporosis Consultants of the Carolinas, Charlotte
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07404865AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Charlotte, Charlotte
- Artiva Investigational Site Charlotte, Charlotte
- Artiva Investigational Site Statesville, Statesville
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT06991114A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- Arthritis and Osteoporosis Consultants of The Carolinas - Charlotte - 1918 Randolph Rd, Charlotte
- Duke Early Phase Clinical Research Unit - PPDS, Durham
- Onsite Clinical Solutions, LLC - Salisbury, Salisbury
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 28, 2026 · NCT06747949Maternal Autoimmune Disease Research Alliance (MADRA) Registry
- Duke University, Durham
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Lahat ng edad · Kababaihan · Na-update Ene 8, 2026 · NCT03276923The Myelin Disorders Biorepository Project
- Atrium Health Wake Forest Baptist, Winston-Salem
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 23, 2025 · NCT03047369Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.